<VariationArchive RecordType="classified" VariationID="2936" VariationName="NM_002076.4(GNS):c.1226dup (p.Ser410fs)" VariationType="Duplication" Accession="VCV000002936" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-07-09" DateCreated="2014-02-20" MostRecentSubmission="2014-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="17975" VariationID="2936">
      <GeneList>
        <Gene Symbol="GNS" FullName="glucosamine (N-acetyl)-6-sulfatase" GeneID="2799" HGNC_ID="HGNC:4422" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="64713449" stop="64759406" display_start="64713449" display_stop="64759406" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="65107221" stop="65153225" display_start="65107221" display_stop="65153225" Strand="-" />
          </Location>
          <OMIM>607664</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002076.4(GNS):c.1226dup (p.Ser410fs)</Name>
      <CanonicalSPDI>NC_000012.12:64723087:C:CC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="64723087" stop="64723088" display_start="64723087" display_stop="64723088" variantLength="1" positionVCF="64723087" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="65116867" stop="65116868" display_start="65116867" display_stop="65116868" variantLength="1" positionVCF="65116867" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>S410fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.65116868dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.65116868dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.64723088dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.64723088dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008955.1" sequenceAccession="NG_008955" sequenceVersion="1" change="g.41359dup">
            <Expression>NG_008955.1:g.41359dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002076.4" sequenceAccession="NM_002076" sequenceVersion="4" change="c.1226dup" MANESelect="true">
            <Expression>NM_002076.4:c.1226dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002067.1" sequenceAccession="NP_002067" sequenceVersion="1" change="p.Ser410fs">
            <Expression>NP_002067.1:p.Ser410fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA115888" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607664.0005" DB="OMIM" />
        <XRef Type="rs" ID="483352900" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002076.4(GNS):c.1226dup (p.Ser410fs) AND Mucopolysaccharidosis, MPS-III-D" Accession="RCV000003070" Version="4">
        <ClassifiedConditionList TraitSetID="745">
          <ClassifiedCondition DB="MedGen" ID="C0086650">Mucopolysaccharidosis, MPS-III-D</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2014-02-20" MostRecentSubmission="2014-02-20">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19650410</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="745" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2971" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-III-D</ElementValue>
                <XRef ID="Mucopolysaccharidosis+type+IIID/4918" DB="Genetic Alliance" />
                <XRef ID="15892005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopoly-saccharidosis type 3D</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sanfilippo syndrome D</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetylglucosamine-6-sulfate sulfatase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 3D</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOPOLYSACCHARIDOSIS, TYPE IIID</ElementValue>
                <XRef Type="MIM" ID="252940" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607664.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607664.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607664.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607664.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="607664.0003" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS III D</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="252940" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS3D</ElementValue>
                <XRef Type="MIM" ID="252940" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7074" />
                <XRef ID="7074" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Mucopolysaccharidosis type III (MPS III) is a multisystem lysosomal storage disease characterized by progressive central nervous system degeneration manifest as severe intellectual disability (ID), developmental regression, and other neurologic manifestations including autism spectrum disorder (ASD), behavioral problems, and sleep disturbances. Disease onset is typically before age ten years. Disease course may be rapidly or slowly progressive; some individuals with an extremely attenuated disease course present in mid-to-late adulthood with early-onset dementia with or without a history of ID. Systemic manifestations can include musculoskeletal problems (joint stiffness, contractures, scoliosis, and hip dysplasia), hearing loss, respiratory tract and sinopulmonary infections, and cardiac disease (valvular thickening, defects in the cardiac conduction system). Neurologic decline is seen in all affected individuals; however, clinical severity varies within and among the four MPS III subtypes (defined by the enzyme involved) and even among members of the same family. Death usually occurs in the second or third decade of life secondary to neurologic regression or respiratory tract infections.</Attribute>
                <XRef ID="NBK546574" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536183</ID>
                <ID Source="BookShelf">NBK546574</ID>
              </Citation>
              <XRef ID="581" DB="Orphanet" />
              <XRef ID="79272" DB="Orphanet" />
              <XRef ID="C0086650" DB="MedGen" />
              <XRef ID="MONDO:0009658" DB="MONDO" />
              <XRef Type="MIM" ID="252940" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23228" SubmissionDate="2014-02-12" DateLastUpdated="2014-02-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607664.0005_MUCOPOLYSACCHARIDOSIS, TYPE IIID" title="GNS, 1-BP INS, 1226G  _MUCOPOLYSACCHARIDOSIS, TYPE IIID" />
        <ClinVarAccession Accession="SCV000023228" DateUpdated="2014-02-20" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 10-year-old Turkish boy with mucopolysaccharidosis type IIID (252940), Elcioglu et al. (2009) identified homozygosity for a 1-bp insertion (1226insG) in exon 11 of the GNS gene, predicted to cause a frameshift and premature termination with loss of the C terminus. The boy's parents were heterozygous for the mutation, which was not found in 100 controls.</Attribute>
              <Citation>
                <ID Source="PubMed">19650410</ID>
              </Citation>
              <XRef DB="OMIM" ID="252940" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNS" />
          </GeneList>
          <Name>GNS, 1-BP INS, 1226G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1226G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607664.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MUCOPOLYSACCHARIDOSIS, TYPE IIID</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="23228" TraitType="Disease" MappingType="Name" MappingValue="MUCOPOLYSACCHARIDOSIS, TYPE IIID" MappingRef="Preferred">
        <MedGen CUI="C0086650" Name="Mucopolysaccharidosis, MPS-III-D" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

